Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD)
Condition(s):Depressive Disorder, Treatment-ResistantLast Updated:February 10, 2020Approved for marketing
Hide Studies Not Open or Pending
Condition(s):Depressive Disorder, Treatment-ResistantLast Updated:February 10, 2020Approved for marketing
Condition(s):Treatment Resistant DepressionLast Updated:February 5, 2024Recruiting
Condition(s):Treatment Resistant DepressionLast Updated:September 15, 2011Unknown status
Condition(s):Treatment Resistant DepressionLast Updated:March 11, 2020Completed
Condition(s):Depressive Disorder, Major; Depressive Disorder, Treatment-ResistantLast Updated:April 4, 2022Completed
Condition(s):Depressive Disorder, Treatment-Resistant; Stress Disorders, Post-TraumaticLast Updated:May 14, 2019Completed
Condition(s):Treatment-resistant DepressionLast Updated:December 22, 2022Not yet recruiting
Condition(s):Treatment Resistant DepressionLast Updated:March 6, 2024Recruiting
Condition(s):Treatment Resistant Depressive DisorderLast Updated:December 27, 2018Unknown status
Condition(s):Treatment Resistant DepressionLast Updated:February 23, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.